Marketing of Pharmaceuticals & OTC

      We were investing 400Cr. through the project "Siddhi"  in following segments pharmaceuticals products Cardiology, Nephrology, Neuro-Psychiatry, Oncology and OTC products with expansion of Psychiatry ranges PAN India. 

          OTC with subject to derma, with cosmetic ranges and new combination in sexual products to attract the middle generation. Because now a days the men are mostly facing erectile disfunction and premature ejaculation. And it became a common syndrome above 35 years men and we also focused on female complications too….

           The Company is also focusing on Cholesterol is one most common problem in recent scenario, and we are trying to bring first time India cholesterol management combination which will help has to catch the poteen market share without any competition. And in Kidney (high creatinine level) and Cancer too. Here also we are trying to bring first time India combination which will help has to catch the poteen market share without any competition.